INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

NCT03071328 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC)
Metastatic Urothelial Carcinoma
Metastatic Renal Cell Carcinoma

Interventions

DRUG: Isovue-M 200

Sponsor

Duke University